|Dr. Anna Petinova||Interim VP of Admin., Interim VP of Fin., Treasurer and Director||N/A||N/A||1964|
|Mr. Hank Midden||VP - Operations||N/A||N/A||1942|
|Mr. John Gernannt||Head of Investor & PR Issues||N/A||N/A||N/A|
|Mr. Peter R. N. Maharaj||VP - Marketing and Pres - Southern Hardwoods||N/A||N/A||1966|
|Mr. Thomas Cripe||Sr. VP of Bus. & Technology Devel.||N/A||N/A||N/A|
|Mr. Tyler Macallister||Controller||N/A||N/A||N/A|
HLK Biotech Holding Group, Inc., through its subsidiaries, produces and sells biodiesel. It also acquires real estate properties. The company was formerly known as Amelot Holdings, Inc. and changed its name to HLK Biotech Holding Group, Inc. in February 2018. HLK Biotech Holding Group, Inc. is headquartered in Norfolk, Virginia.
HLK Biotech Holding Group, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.